Citigroup’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-7,289
| Closed | -$27K | – | 5133 |
|
|
2017
Q4 | $27K | Buy |
7,289
+5,269
| +261% | +$19.5K | ﹤0.01% | 4121 |
|
|
2017
Q3 | $8K | Buy |
2,020
+1,793
| +790% | +$7.1K | ﹤0.01% | 4274 |
|
|
2017
Q2 | $1K | Buy |
227
+69
| +44% | +$304 | ﹤0.01% | 4833 |
|
|
2017
Q1 | $1K | Sell |
158
-33
| -17% | -$209 | ﹤0.01% | 4775 |
|
|
2016
Q4 | $1K | Sell |
191
-3,541
| -95% | -$18.5K | ﹤0.01% | 4829 |
|
|
2016
Q3 | $37K | Buy |
3,732
+1,751
| +88% | +$17.4K | ﹤0.01% | 3895 |
|
|
2016
Q2 | $11K | Sell |
1,981
-13,143
| -87% | -$73K | ﹤0.01% | 4496 |
|
|
2016
Q1 | $115K | Buy |
15,124
+6,584
| +77% | +$50.1K | ﹤0.01% | 3870 |
|
|
2015
Q4 | $114K | Buy |
8,540
+8,471
| +12,277% | +$113K | ﹤0.01% | 3502 |
|
|
2015
Q3 | $1K | Sell |
69
-327
| -83% | -$4.74K | ﹤0.01% | 5135 |
|
|
2015
Q2 | $8K | Sell |
396
-549
| -58% | -$11.1K | ﹤0.01% | 4713 |
|
|
2015
Q1 | $9K | Sell |
945
-1,448
| -61% | -$13.8K | ﹤0.01% | 4822 |
|
|
2014
Q4 | $27K | Sell |
2,393
-3,394
| -59% | -$38.3K | ﹤0.01% | 4458 |
|
|
2014
Q3 | $67K | Buy |
5,787
+334
| +6% | +$3.87K | ﹤0.01% | 3458 |
|
|
2014
Q2 | $106K | Sell |
5,453
-223
| -4% | -$4.34K | ﹤0.01% | 3036 |
|
|
2014
Q1 | $102K | Sell |
5,676
-152
| -3% | -$2.73K | ﹤0.01% | 3471 |
|
|
2013
Q4 | $62K | Sell |
5,828
-2,017
| -26% | -$21.5K | ﹤0.01% | 4040 |
|
|
2013
Q3 | $97K | Buy |
7,845
+2,050
| +35% | +$25.3K | ﹤0.01% | 3157 |
|
|
2013
Q2 | $54K | Buy |
+5,795
| New | +$54K | ﹤0.01% | 3729 |
|